Extent Research Assistant ×
📩 [email protected] | 📞 +1 (212) 951-1369

Request Sample/Pricing Details:

💬
Extent Research Global Chorea Treatment Market
REPORT DETAILS FREE ANALYSIS INQUIRY FOR BUYING REQUEST SAMPLE
Home / Medical Care / Global Chorea Treatment Market

Global Chorea Treatment Market

Comprehensive industry overview, market size, share, trends, and forecast analysis.

Medical Care Nov 2019 Global 350 Pages No of Tables: 220 No of Figures: 60 Reviewed By: Priya M Author: Julie
Request for TOC Speak to Analyst Inquire Before Buying Download Free Sample PDF

Global Chorea Treatment Market

Market Size in USD Billion

CAGR : 17.60%
USD 1.14
2025
USD 4.17
2033
Forecast Period 2025 - 2033
Market Size (Base Year) USD 1.14 Billion
Market Size (Forecast) USD 4.17 Billion
CAGR 17.60%
Major Market Players Data provided in full report

After conducting exhaustive primary and secondary research, Extent Research has published a cutting-edge and comprehensive report on the global Chorea Treatment market. The report encompasses all the vital as well as authentic information related to the Chorea Treatment market. Factual and statistical information associated with the global Chorea Treatment market such as valuation, capitalization, manufacturing or delivery rate, and the demand-supply ratio is thoroughly explicated in the report. Moreover, the global Chorea Treatment market report depicts crucial financial information such as global share, CAGR, quarterly and yearly revenue generation, assets’ value, and losses incurred during the past several fiscal years.

Data provided by Extent Research. Source: https://www.extentresearch.com/chorea-treatment-market

For maintaining the intelligibility of the market study published in the global Chorea Treatment market report, the information related to the enterprises falling in the same category is presented in a single section of the report. Indubitably, the report enlightens some vital aspects of the Chorea Treatment market, which include quality of product or service, sagacious business approaches, burgeoning trends, and potential economic crisis, among others. The report underlines the competitive landscape of the global Chorea Treatment market by delivering all the important data associated with the valuation and supremacy of the competing market players, raw material trading, vendor relations, and so on. Some of the leading organizations governing the global Chorea Treatment market are Medtronic, Boston Scientific, Aleva Neurotherapeutics, Teva Pharmaceutical, Pfizer, GlaxoSmithKline, Bausch Health Companies, LivaNova, Lundbeck, Ipsen, Alnylam Pharmaceuticals, Prana Biotechnology, RespireRx Pharmaceuticals, Vertex Pharmaceuticals, SOM Biotech, .

Apart from industries falling under very few sectors, all the remaining organizations underwent a huge financial downfall during the COVID-19 pandemic. Currently, the global Chorea Treatment market is adopting some pragmatic strategies in order to get the business back on track. Some of the renowned tactics being followed by an enterprise to effectually recover the losses are also clearly explained in this report. Apart from this, the global Chorea Treatment market report delivers a comprehensive analysis of the market by bifurcating it into multifarious segments Product type Medication, Surgery Therapy, by Application Hospitals, Clinics, Others, .

Report Scope and Market Segmentation

ATTRIBUTES Global Chorea Treatment Market KEY MARKET INSIGHTS
Segments Covered
  • By Product Type: All Products Type Includes
  • By Application: All Application Type Includes
  • By End User: All End User Type Includes
  • By Distribution Channel: All Distribution Channel Includes
Countries Covered
  • North America
    • U.S., Canada, Mexico
  • Europe
    • Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe
  • Asia-Pacific
    • China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific
  • Latin America
    • Brazil, Argentina, Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players
  • Leading Tier 1 Corporations
  • Prominent Regional Manufacturers
  • Emerging Market Disruptors
  • Technology Integrators & Suppliers
  • *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities
  • Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability.
  • Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands.
  • Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities.
  • Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry.
  • Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...
Read more about Julie
Priya M

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...
Learn more about Priya M
BASIC ATTRIBUTES | KEY MARKET INSIGHTS
Report Title Global Chorea Treatment Market
Base Year 2025
Forecast Period 2025 - 2033
Market Size (Base) USD 1.14 Billion
Projected Size USD 4.17 Billion
CAGR 17.60%

Table of Contents

1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Chorea Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2035 1.2.2 Medication 1.2.3 Surgery Therapy 1.3 Market by Application 1.3.1 Global Chorea Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2035 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Chorea Treatment Market Perspective (2017-2035) 2.2 Chorea Treatment Growth Trends by Region 2.2.1 Chorea Treatment Market Size by Region: 2017 VS 2021 VS 2035 2.2.2 Chorea Treatment Historic Market Size by Region (2017-2022) 2.2.3 Chorea Treatment Forecasted Market Size by Region (2023-2035) 2.3 Chorea Treatment Market Dynamics 2.3.1 Chorea Treatment Industry Trends 2.3.2 Chorea Treatment Market Drivers 2.3.3 Chorea Treatment Market Challenges 2.3.4 Chorea Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Chorea Treatment Players by Revenue 3.1.1 Global Top Chorea Treatment Players by Revenue (2017-2022) 3.1.2 Global Chorea Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Chorea Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Chorea Treatment Revenue 3.4 Global Chorea Treatment Market Concentration Ratio 3.4.1 Global Chorea Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Chorea Treatment Revenue in 2021 3.5 Chorea Treatment Key Players Head office and Area Served 3.6 Key Players Chorea Treatment Product Solution and Service 3.7 Date of Enter into Chorea Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Chorea Treatment Breakdown Data by Type 4.1 Global Chorea Treatment Historic Market Size by Type (2017-2022) 4.2 Global Chorea Treatment Forecasted Market Size by Type (2023-2035) 5 Chorea Treatment Breakdown Data by Application 5.1 Global Chorea Treatment Historic Market Size by Application (2017-2022) 5.2 Global Chorea Treatment Forecasted Market Size by Application (2023-2035) 6 North America 6.1 North America Chorea Treatment Market Size (2017-2035) 6.2 North America Chorea Treatment Market Size by Type 6.2.1 North America Chorea Treatment Market Size by Type (2017-2022) 6.2.2 North America Chorea Treatment Market Size by Type (2023-2035) 6.2.3 North America Chorea Treatment Market Share by Type (2017-2035) 6.3 North America Chorea Treatment Market Size by Application 6.3.1 North America Chorea Treatment Market Size by Application (2017-2022) 6.3.2 North America Chorea Treatment Market Size by Application (2023-2035) 6.3.3 North America Chorea Treatment Market Share by Application (2017-2035) 6.4 North America Chorea Treatment Market Size by Country 6.4.1 North America Chorea Treatment Market Size by Country (2017-2022) 6.4.2 North America Chorea Treatment Market Size by Country (2023-2035) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Chorea Treatment Market Size (2017-2035) 7.2 Europe Chorea Treatment Market Size by Type 7.2.1 Europe Chorea Treatment Market Size by Type (2017-2022) 7.2.2 Europe Chorea Treatment Market Size by Type (2023-2035) 7.2.3 Europe Chorea Treatment Market Share by Type (2017-2035) 7.3 Europe Chorea Treatment Market Size by Application 7.3.1 Europe Chorea Treatment Market Size by Application (2017-2022) 7.3.2 Europe Chorea Treatment Market Size by Application (2023-2035) 7.3.3 Europe Chorea Treatment Market Share by Application (2017-2035) 7.4 Europe Chorea Treatment Market Size by Country 7.4.1 Europe Chorea Treatment Market Size by Country (2017-2022) 7.4.2 Europe Chorea Treatment Market Size by Country (2023-2035) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Chorea Treatment Market Size (2017-2035) 8.2 Asia-Pacific Chorea Treatment Market Size by Type 8.2.1 Asia-Pacific Chorea Treatment Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Chorea Treatment Market Size by Type (2023-2035) 8.2.3 Asia-Pacific Chorea Treatment Market Share by Type (2017-2035) 8.3 Asia-Pacific Chorea Treatment Market Size by Application 8.3.1 Asia-Pacific Chorea Treatment Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Chorea Treatment Market Size by Application (2023-2035) 8.3.3 Asia-Pacific Chorea Treatment Market Share by Application (2017-2035) 8.4 Asia-Pacific Chorea Treatment Market Size by Region 8.4.1 Asia-Pacific Chorea Treatment Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Chorea Treatment Market Size by Region (2023-2035) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Chorea Treatment Market Size (2017-2035) 9.2 Latin America Chorea Treatment Market Size by Type 9.2.1 Latin America Chorea Treatment Market Size by Type (2017-2022) 9.2.2 Latin America Chorea Treatment Market Size by Type (2023-2035) 9.2.3 Latin America Chorea Treatment Market Share by Type (2017-2035) 9.3 Latin America Chorea Treatment Market Size by Application 9.3.1 Latin America Chorea Treatment Market Size by Application (2017-2022) 9.3.2 Latin America Chorea Treatment Market Size by Application (2023-2035) 9.3.3 Latin America Chorea Treatment Market Share by Application (2017-2035) 9.4 Latin America Chorea Treatment Market Size by Country 9.4.1 Latin America Chorea Treatment Market Size by Country (2017-2022) 9.4.2 Latin America Chorea Treatment Market Size by Country (2023-2035) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Chorea Treatment Market Size (2017-2035) 10.2 Middle East & Africa Chorea Treatment Market Size by Type 10.2.1 Middle East & Africa Chorea Treatment Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Chorea Treatment Market Size by Type (2023-2035) 10.2.3 Middle East & Africa Chorea Treatment Market Share by Type (2017-2035) 10.3 Middle East & Africa Chorea Treatment Market Size by Application 10.3.1 Middle East & Africa Chorea Treatment Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Chorea Treatment Market Size by Application (2023-2035) 10.3.3 Middle East & Africa Chorea Treatment Market Share by Application (2017-2035) 10.4 Middle East & Africa Chorea Treatment Market Size by Country 10.4.1 Middle East & Africa Chorea Treatment Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Chorea Treatment Market Size by Country (2023-2035) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Medtronic 11.1.1 Medtronic Company Details 11.1.2 Medtronic Business Overview 11.1.3 Medtronic Chorea Treatment Introduction 11.1.4 Medtronic Revenue in Chorea Treatment Business (2017-2022) 11.1.5 Medtronic Recent Developments 11.2 Boston Scientific 11.2.1 Boston Scientific Company Details 11.2.2 Boston Scientific Business Overview 11.2.3 Boston Scientific Chorea Treatment Introduction 11.2.4 Boston Scientific Revenue in Chorea Treatment Business (2017-2022) 11.2.5 Boston Scientific Recent Developments 11.3 Aleva Neurotherapeutics 11.3.1 Aleva Neurotherapeutics Company Details 11.3.2 Aleva Neurotherapeutics Business Overview 11.3.3 Aleva Neurotherapeutics Chorea Treatment Introduction 11.3.4 Aleva Neurotherapeutics Revenue in Chorea Treatment Business (2017-2022) 11.3.5 Aleva Neurotherapeutics Recent Developments 11.4 Teva Pharmaceutical 11.4.1 Teva Pharmaceutical Company Details 11.4.2 Teva Pharmaceutical Business Overview 11.4.3 Teva Pharmaceutical Chorea Treatment Introduction 11.4.4 Teva Pharmaceutical Revenue in Chorea Treatment Business (2017-2022) 11.4.5 Teva Pharmaceutical Recent Developments 11.5 Pfizer 11.5.1 Pfizer Company Details 11.5.2 Pfizer Business Overview 11.5.3 Pfizer Chorea Treatment Introduction 11.5.4 Pfizer Revenue in Chorea Treatment Business (2017-2022) 11.5.5 Pfizer Recent Developments 11.6 GlaxoSmithKline 11.6.1 GlaxoSmithKline Company Details 11.6.2 GlaxoSmithKline Business Overview 11.6.3 GlaxoSmithKline Chorea Treatment Introduction 11.6.4 GlaxoSmithKline Revenue in Chorea Treatment Business (2017-2022) 11.6.5 GlaxoSmithKline Recent Developments 11.7 Bausch Health Companies 11.7.1 Bausch Health Companies Company Details 11.7.2 Bausch Health Companies Business Overview 11.7.3 Bausch Health Companies Chorea Treatment Introduction 11.7.4 Bausch Health Companies Revenue in Chorea Treatment Business (2017-2022) 11.7.5 Bausch Health Companies Recent Developments 11.8 LivaNova 11.8.1 LivaNova Company Details 11.8.2 LivaNova Business Overview 11.8.3 LivaNova Chorea Treatment Introduction 11.8.4 LivaNova Revenue in Chorea Treatment Business (2017-2022) 11.8.5 LivaNova Recent Developments 11.9 Lundbeck 11.9.1 Lundbeck Company Details 11.9.2 Lundbeck Business Overview 11.9.3 Lundbeck Chorea Treatment Introduction 11.9.4 Lundbeck Revenue in Chorea Treatment Business (2017-2022) 11.9.5 Lundbeck Recent Developments 11.10 Ipsen 11.10.1 Ipsen Company Details 11.10.2 Ipsen Business Overview 11.10.3 Ipsen Chorea Treatment Introduction 11.10.4 Ipsen Revenue in Chorea Treatment Business (2017-2022) 11.10.5 Ipsen Recent Developments 11.11 Alnylam Pharmaceuticals 11.11.1 Alnylam Pharmaceuticals Company Details 11.11.2 Alnylam Pharmaceuticals Business Overview 11.11.3 Alnylam Pharmaceuticals Chorea Treatment Introduction 11.11.4 Alnylam Pharmaceuticals Revenue in Chorea Treatment Business (2017-2022) 11.11.5 Alnylam Pharmaceuticals Recent Developments 11.12 Prana Biotechnology 11.12.1 Prana Biotechnology Company Details 11.12.2 Prana Biotechnology Business Overview 11.12.3 Prana Biotechnology Chorea Treatment Introduction 11.12.4 Prana Biotechnology Revenue in Chorea Treatment Business (2017-2022) 11.12.5 Prana Biotechnology Recent Developments 11.13 RespireRx Pharmaceuticals 11.13.1 RespireRx Pharmaceuticals Company Details 11.13.2 RespireRx Pharmaceuticals Business Overview 11.13.3 RespireRx Pharmaceuticals Chorea Treatment Introduction 11.13.4 RespireRx Pharmaceuticals Revenue in Chorea Treatment Business (2017-2022) 11.13.5 RespireRx Pharmaceuticals Recent Developments 11.14 Vertex Pharmaceuticals 11.14.1 Vertex Pharmaceuticals Company Details 11.14.2 Vertex Pharmaceuticals Business Overview 11.14.3 Vertex Pharmaceuticals Chorea Treatment Introduction 11.14.4 Vertex Pharmaceuticals Revenue in Chorea Treatment Business (2017-2022) 11.14.5 Vertex Pharmaceuticals Recent Developments 11.15 SOM Biotech 11.15.1 SOM Biotech Company Details 11.15.2 SOM Biotech Business Overview 11.15.3 SOM Biotech Chorea Treatment Introduction 11.15.4 SOM Biotech Revenue in Chorea Treatment Business (2017-2022) 11.15.5 SOM Biotech Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst
TESTIMONIALS

What our clients say about us ?

★★★★★

"The standard report was strong from the beginning. What truly added value was the collaboration with the researchers we could openly discuss market insights and request additional data and analyses over several rounds."

Client

Michael Heidecker

Founder and Managing Director

★★★★★

"Extent Research delivered exactly what we needed reliable data, competitive pricing, and outstanding support. Their team was responsive, collaborative, and enhanced the report with custom insights every step of the way."

Client

Dr. Bernd Binder

Product Manager

★★★★★

"Super quick and helpful support even during the holidays! I really appreciated the effort. The report quality was excellent, with clear details and great insights that helped me understand the progress easily. Thank you so much!"

Client

Ryoko Tanaka

Head of Planning Dept

Top Brands That Trust Us

×
Julie
View Profile

Julie

Head of Research & Multidisciplinary Strategist

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly balances analytical rigor with sharp business acumen. Throughout her impressive career, she has evolved from a dedicated research analyst into a visionary leader who specializes in decoding complex market dynamics, analyzing competitive landscapes, and identifying emerging global trends. Her primary mission is to transform raw, intricate data into forward-looking strategies and actionable intelligence that empower stakeholders to make highly informed, strategic decisions.

Data provided by Extent Research. Source: https://www.extentresearch.com/chorea-treatment-market

Under her expert leadership, the team at Extent Research consistently delivers top-tier insights across an incredibly diverse array of international sectors. Whenever she oversees the development of a comprehensive Market Research Report, she ensures that it meticulously covers the specific nuances of the client’s target industry. Her multidisciplinary approach allows her to seamlessly integrate economic indicators and industry intelligence across vast domains. Her remarkable portfolio of sector expertise spans foundational global industries like Agriculture, Chemical & Material, Machinery & Equipment, Automobile & Transportation, Energy & Power, and Aerospace and Defense. Furthermore, she provides critical strategic oversight in fast-paced consumer and tech markets, including Consumer Goods, Food & Beverages, Packaging, Electronics & Semiconductor, Internet & Communication, New Technology, and Service & Software. Her expansive analytical reach also deeply penetrates life sciences and wellness fields, delivering precise data for Medical Care, Medical Devices & Consumables, and Pharma & Healthcare.

Recognized industry-wide for designing highly effective, customized research methodologies, Julie brings a uniquely visionary approach to strategic consulting. She integrates deep data analysis with a macro-economic perspective, ensuring that every piece of industry intelligence is fully utilized to drive meaningful business transformations. Her exceptional ability to work fluidly across so many complex sectors gives her clients a distinct competitive advantage in highly saturated markets. Ultimately, Julie Jayne’s leadership is the driving force behind Extent Research’s unwavering commitment to delivering elite, actionable insights, proving her to be an invaluable asset to organizations looking to navigate the future of global commerce.

Domain Assigned: Multiple Sectors
×
Priya M
View Profile

Priya M

Vice President

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives with highly tailored, research-backed solutions. She brings a wealth of strategic experience to the table, ensuring that decision-makers are armed with the precise intelligence required to navigate highly competitive and rapidly evolving global markets.

Data provided by Extent Research. Source: https://www.extentresearch.com/chorea-treatment-market

Currently serving as a foundational pillar at Extent Research, Priya operates as the primary driving force behind the firm’s unwavering commitment to analytical excellence. She acts as the vital linchpin within the organization’s comprehensive research pipeline, meticulously reviewing and vetting all incoming data and outgoing insights. Her rigorous quality control guarantees that every single Market Research Report published meets elite industry standards for accuracy, relevance, and clarity. Through her steadfast dedication to precision, she ensures that clients receive reliable, transformative intelligence tailored directly to their long-term strategic needs.

Cross-Industry Expertise

Priya’s exceptional analytical prowess is not confined to a single niche. Rather, she possesses a broad, cross-industry expertise that allows her to expertly decode intricate market shifts and uncover hidden economic patterns. Her ability to synthesize complex technological innovations and sector-specific developments allows her to offer fresh, multifaceted perspectives. She expertly oversees data, forecasts, and emerging trends across an expansive spectrum of global industries, including:

  • Aerospace and Defense
  • Agriculture
  • Automobile & Transportation
  • Chemical & Material
  • Consumer Goods
  • Electronics & Semiconductor
  • Energy & Power
  • Food & Beverages
  • Internet & Communication
  • Machinery & Equipment
  • Medical Care
  • Medical Devices & Consumables
  • New Technology
  • Packaging
  • Pharma & Healthcare
  • Service & Software

Transforming Data into Strategy

By analyzing cross-domain developments across these diverse sectors, Priya effortlessly translates highly technical and complex datasets into digestible, actionable intelligence. She does not merely report static facts; she actively brings the intricate world of market intelligence to life, making it highly engaging and educational for investors, seasoned professionals, and corporate leaders alike.

Her exceptional attention to detail and her innate ability to forecast tomorrow’s emerging innovations keep her and her global clientele consistently one step ahead of the curve. Ultimately, Priya M’s unwavering dedication to precision, combined with her forward-thinking methodology, makes her an indispensable asset to the industry. She guarantees that every piece of strategic advice delivered is backed by rigorous, world-class research.

Domain Assigned: Multiple Sectors